Background: Production of β-lactamase enzymes by Gram-negative bacteria is the most
common mechanism to acquire drug resistance to β-lactam antibiotics. Limitations in …

BACKGROUND: Extended-spectrum beta-lactamase (ESBL)-producing organisms
inactivate extended beta-lactam antibiotics and monobactams and also exhibit coresistance …

Emergence of antibiotic resistance among pathogens, particularly in health centers and
hospitals, has become a major public health problem. This study identified AmpC-type beta …

Objectives There is an extensive incidence of extended-spectrum beta-lactamases (ESBLs),
principally in the hospital environment across the world. The present study was designed to …

Background. Emergence of pathogenic bacteria carrying β‐lactamase‐resistant
determinants has become a major health problem in the hospital setting. The study aimed to …

Aims: To study the prevalence of extended spectrum β-lactamase (ESBL) producing
Enterobacteriaceae and coresistance to other commonly used antibiotics from the Bhopal …

Objective: This study was attempted to evaluate the prevalence of extended spectrum beta-
lactamase (ESBL) among Enterobacteriaceae from different clinical samples from a tertiary …

Background Extended-spectrum b-lactamase (ESBL) producing bacteria are growing in
number worldwide and cause complications in antibiotic therapy for patients, thus raising …

The prevalence and molecular epidemiology of Escherichia coli that produce extended
spectrum β-lactamase (ESBL) in Cairo, Egypt was investigated. Ninety E. coli isolates were …

Objective: To determine the susceptibility pattern of extended spectrum ß-lactamase (ESBL)
producing Gram negative isolates from various clinical specimens. Study Design …